Gene Therapy Slows Huntington’s by 75% in ‘Groundbreaking’ Clinical Trial
Doctors in the UK are claiming to have performed a monumental medical breakthrough. Using a form of gene therapy, they successfully treated—for the first time—the neurodegenerative disorder Huntington’s disease. On Wednesday, the company uniQure announced the results of its phase I/II trial testing the therapy, code-named AMT-130. The trial, conducted with the help of researchers from University College London, found that AMT-130 slowed the progression of people’s symptoms by 75%. It also appea